The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The investigators evaluated the efficacy of a single early intravesical instillation of
doxetaxel in the prevention of bladder recurrence after nephroureterectomy or distal
ureterectomy for upper urinary tract urothelial carcinoma (UUT-UC).